Effect of coadministered ezetimibe and fenofibrate on the atherogenic dyslipidemia in obese patients with mixed hyperlipidemia

被引：0
|
作者：
Davies, M
Shah, A
Macdonell, G
Gumbiner, B
机构：
来源：
OBESITY RESEARCH | 2005年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A132 / A133
页数：2
相关论文
共 50 条
  • [21] CONCOMITANT ADMINISTRATION OF STATIN AND FENOFIBRATE IN PATIENTS WITH MIXED DYSLIPIDEMIA
    Rosolova, H.
    Ceska, R.
    Soska, V.
    Soucek, M.
    Pelikanova, T.
    Blaha, V.
    Sucharda, P.
    Hamouz, Z.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 249 - 249
  • [22] Efficacy and safety of the coadministration of ezetimibe with fenofibrate in patients with mixed hyperlipidaemia
    Farnier, M
    Freeman, MW
    Macdonell, G
    Perevozskaya, I
    Davies, MJ
    Mitchel, YB
    Gumbiner, B
    EUROPEAN HEART JOURNAL, 2005, 26 (09) : 897 - 905
  • [23] Effectiveness of treatment with statins and ezetimibe in patients with hypercholesterolemia and mixed dyslipidemia
    Esteban-Salan, M.
    Guimon-Bardesi, A.
    Viuda-Unceta, J. M.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 553 - 554
  • [24] EFFICACY AND SAFETY OF EZETIMIBE/SIMVASTATIN COADMINISTERED WITH EXTENDED RELEASE NIACIN IN PATIENTS WITH TYPE IIA OR IIB HYPERLIPIDEMIA
    Fazio, S.
    Brown, B. G.
    Guyton, J. R.
    Polis, A.
    Tomassini, J. E.
    Tershakovec, A. M.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 16 - 16
  • [25] Efficacy and safety of Ezetimibe/Simvastatin coadministered with extended release niacin in patients with type IIa or IIb Hyperlipidemia
    Fazio, Sergio
    Brown, B. Greg
    Guyton, John R.
    Polis, Adam
    Tomassini, Joanne E.
    Tershakovec, Andrew M.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : A325 - A325
  • [26] Effects of the co-administration of ezetimibe/simvastatine and fenofibrate on the lipoproteins sub-classes and on the LDL size profile in patients with mixed hyperlipidemia
    Farnier, M.
    Perevozskaya, I.
    Taggart, W.
    Kush, D.
    Mitchel, Y.
    DIABETES & METABOLISM, 2007, 33 : S59 - S60
  • [27] Effect of fenofibrate on LDL subfractions in patients with combined dyslipidemia
    Tsimihodimos, V
    Irene, G
    Tselepis, A
    Bairaktari, E
    Elisaf, M
    ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (01) : 154 - 155
  • [28] Hemostatic effects of fenofibrate in patients with mixed dyslipidemia and impaired fasting glucose
    Robert Krysiak
    Gabriela Handzlik
    Bogusław Okopień
    Pharmacological Reports, 2010, 62 : 1099 - 1107
  • [29] Hemostatic effects of fenofibrate in patients with mixed dyslipidemia and impaired fasting glucose
    Krysiak, Robert
    Handzlik, Gabriela
    Okopien, Boguslaw
    PHARMACOLOGICAL REPORTS, 2010, 62 (06) : 1099 - 1107
  • [30] CHANGES IN LIPOPROTEIN PARTICLE NUMBER WITH EZETIMIBE/SIMVASTATIN COADMINISTERED WITH EXTENDED-RELEASE NIACIN IN PATIENTS WITH TYPE II HYPERLIPIDEMIA
    Le, Anh
    Jin, Ran
    Tershakovec, Andrew
    Neff, David
    Tomassini, Joanne
    Otvos, James
    Wilson, Peter
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E1691 - E1691
12345